MichaelRezakMD

Neurology • Hoffman Estates, IL

Movement Disorder

Physician

Join to view full profile

Dr. Rezak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rezak's full profile

Already have an account?

Office
1555 N. Barrington Road
DOB 3 Suite 2400
Hoffman Estates, IL 60169
Phone+1 847-981-3630

Fax+1 847-981-3633
Is this information wrong?

Education & Training

Yale-New Haven Medical CenterResidency, Neurology, 1987 - 1989
Rush University Medical CenterResidency, Internal Medicine, 1985 - 1987
Loyola University Chicago Stritch School of MedicineClass of 1985

Certifications & Licensure

IL State Medical License 1985 - 2026
NY State Medical License 2018 - 2022
CT State Medical License 2018 - 2021
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

West Suburban Living Magazine Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

5 citations
Prospective Evaluation of the Time Course of White Matter Edema Associated with Implanted Deep Brain Stimulation Electrodes.
Mark J. Nolt, Rajeev S. Polasani, Taras W. Masnyk, Michael Rezak, Joshua M. Rosenow> ;Stereotactic and Functional Neurosurgery. 2021 May 1
2 citations
Disease modification in neurodegenerative diseases: Not quite there yet.
Michael Rezak, Mamede de Carvalho> ;Neurology. 2020 Jan 7
13 citations
The relationship between obsessive‐compulsive symptoms and PARKIN genotype: The CORE‐PD study
Madeleine Sharp, Elise Caccappolo, Helen Mejia-Santana, Ming X. Tang, Llency Rosado, Martha Orbe Reilly, Diana Ruiz, Elan D. Louis, Cynthia L. Comella, Martha Nance, S...> ;Movement Disorders. 2015 Feb 1
8 citations
Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscan™)
Cummings Jl, Michael J Fine, Grachev Id, Jarecke Cr, Johnson Mk, Phillip H. Kuo, Schaecher Kl, Oberdorf Ja, Rezak M, Riley De, Truong D> ;The American Journal of Managed Care. 2014 Mar 24
44 citations
Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.
Roy N. Alcalay, Elise Caccappolo, Helen Mejia-Santana, Ming Xin Tang, Llency Rosado, Martha Orbe Reilly, Diana Ruiz, Elan D. Louis, Cynthia L. Comella, Martha Nance, S...> ;JAMA Neurology. 2014 Jan 1
44 citations
Current pharmacotherapeutic treatment options in Parkinson's disease.
Michael Rezak> ;Disease-a-Month. 2007 Apr 1
189 citations
Cognitive performance of GBA mutation carriers with early-onset PD The CORE-PD study
Roy N. Alcalay, E. Caccappolo, Helen Mejia-Santana, Ming-Xin Tang, Llency Rosado, M. Orbe Reilly, Diana Ruiz, Barbara Ross, M. Verbitsky, Sergey Kisselev, Elan D. Loui...> ;Neurology. 2012 May 1
28 citations
The relation between depression and parkin genotype: the CORE-PD study.
A. Srivastava, Ming-Xin Tang, Helen Mejia-Santana, Llency Rosado, Elan D. Louis, Elise Caccappolo, Cynthia L. Comella, Amy Colcher, Andrew Siderowf, Danna Jennings, M....> ;Parkinsonism & Related Disorders. 2011 Dec 1
23 citations
Neuropsychological profile of parkin mutation carriers with and without Parkinson disease: the CORE-PD study
Elise Caccappolo, Roy N. Alcalay, Helen Mejia-Santana, Ming X. Tang, Brian C. Rakitin, Llency Rosado, Elan D. Louis, Cynthia L. Comella, Amy Colcher, Danna Jennings, M...> ;Journal of the International Neuropsychological Society. 2011 Jan 1
105 citations
Frequency of Known Mutations in Early-Onset Parkinson Disease: Implication for Genetic Counseling: The Consortium on Risk for Early Onset Parkinson Disease Study
Roy N. Alcalay, Elise Caccappolo, Helen Mejia-Santana, Ming Xin Tang, Llency Rosado, Barbara Ross, Miguel Verbitsky, Sergey Kisselev, Elan D. Louis, Cynthia L. Comella...> ;Archives of Neurology. 2010 Sep 13
72 citations
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.
Karen Marder, Ming X. Tang, Helen Mejia-Santana, Llency Rosado, Elan D. Louis, Cynthia L. Comella, Amy Colcher, Andrew Siderowf, Danna Jennings, Martha Nance, Susan B....> ;Archives of Neurology. 2010 Jun 1
44 citations
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease
Roy N. Alcalay, Helen Mejia-Santana, Ming X. Tang, Brian C. Rakitin, Llency Rosado, Barbara Ross, Miguel Verbitsky, Sergey Kisselev, Elan D. Louis, Cynthia L. Comella,...> ;Journal of Clinical and Experimental Neuropsychology. 2010 Feb 24
48 citations
Motor Phenotype of LRRK2 G2019S Carriers in Early-Onset Parkinson Disease
Roy N. Alcalay, Helen Mejia-Santana, Ming Xin Tang, Llency Rosado, Miguel Verbitsky, Sergey Kisselev, Barbara Ross, Elan D. Louis, Cynthia L. Comella, Amy Colcher, Dan...> ;Archives of Neurology. 2009 Dec 1
7 citations
Reversible corneal edema associated with amantadine use: an unrecognized problem.
Jordan S. Dubow, Michael Rezak, Andrew A. Berman> ;Movement Disorders. 2008 Oct 30
Acute dystonic reaction associated with foscarnet administration.
Jordan Dubow, Stephanie R Panush, Michael Rezak, Jerrold B. Leikin> ;American Journal of Therapeutics. 2008 Mar 1
30 citations
Successful bilateral subthalamic nucleus stimulation for segmental dystonia after unilateral pallidotomy.
Kevin Novak, Emmanuel K. Nenonene, Lawrence P. Bernstein, Sandra Vergenz, Jeffrey W. Cozzens, Michael Rezak> ;Stereotactic and Functional Neurosurgery. 2008 Jan 1
2 citations
Complications of dopaminergic therapy
Amy Kessler, Michael Rezak> ;Disease-a-Month. 2007 Apr 1
5 citations
Acute chorea associated with metoclopramide use.
Jordan Dubow, Jerrold B. Leikin, Michael Rezak> ;American Journal of Therapeutics. 2006 Nov 1
19 citations
Two cases of ischemia associated with subthalamic nucleus stimulator implantation for advanced Parkinson's disease
Kevin Novak, Emmanuel K. Nenonene, Lawrence P. Bernstein, Sandra Vergenz, Gina Medalle, Jordan M. Prager, Theodore W. Eller, Jeffrey W. Cozzens, Michael Rezak> ;Movement Disorders. 2006 Sep 1
5 citations
Visual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injections
Jordan Dubow, Angela Kim, Jerrold B. Leikin, Kirk L Cumpston, Sean M. Bryant, Michael Rezak> ;Movement Disorders. 2005 Jul 1
9 citations
Qualitative analysis of verbal fluency before and after unilateral pallidotomy.
George J. Demakis, Michael G. Mercury, Jerry J. Sweet, Michael Rezak, Theodore W. Eller, Sandy Vergenz> ;The Clinical Neuropsychologist. 2003 Aug 1
1 citations
Facial nerve neuritis secondary to ultraviolet radiation.
Sean M. Bryant, Kirk L. Cumpston, Jerrold B. Leikin, Mark B. Mycyk, Erin M. Pallasch, Michael Rezak> ;Veterinary and Human Toxicology. 2003 Aug 1
9 citations
Motor and cognitive sequelae of unilateral pallidotomy in intractable Parkinson's Disease: electronic measurement of motor steadiness is a useful outcome measure.
George J. Demakis, Michael G. Mercury, Jerry J. Sweet, Michael Rezak, Theodore W. Eller, Sandy Vergenz> ;Journal of Clinical and Experimental Neuropsychology. 2002 Aug 1
38 citations
Olfaction in Parkin heterozygotes and compound heterozygotes The CORE-PD study
Roy N. Alcalay, A. Siderowf, Ruth Ottman, E. Caccappolo, Helen Mejia-Santana, Ming-Xin Tang, Llency Rosado, E. Louis, Diana Ruiz, Cheryl Waters, Stanley Fahn, Lucien J...> ;Neurology. 2011 Jan 25
Burning chest pain.
Ramp, J., Rezak, M., Simon, L., Wurtz, R.> ;N Engl J Med. 1985 Dec 26
Join now to see all

Press Mentions

Stronger, More Resilient: Hospitals Respond to Pandemic with Growth, ChangeMay 12th, 2021
The Truth About Essential Tremor: It’s Not Just a Case of NervesNovember 11th, 2015